Literature DB >> 8453149

Cutaneous ossification in Albright's hereditary osteodystrophy.

R M Trüeb1, R G Panizzon, G Burg.   

Abstract

A 23-year-old woman presented with subcutaneous ossification, which together with short stature, stocky physique, round face and brachydactyly suggested Albright's hereditary osteodystrophy (AHO). Serum calcium and phosphorus levels were normal. AHO refers to the phenotype of the syndromes of pseudo-hypoparathyroidism (PHP) type Ia and pseudopseudohypoparathyroidism (PPHP), both considered genetically related variants with a defect of the alpha subunit of the stimulatory G protein of adenylate cyclase, necessary for the action of parathyroid and other hormones using cyclic AMP as an intracellular second messenger. PPHP differs from PHP in that it lacks parathyroid hormone resistance manifesting itself as hypocalcemia. Other endocrine end organ unresponsiveness, e.g. hypothyroidism and hypogonadism, may also be found with PHP. Both PHP and PPHP usually exhibit characteristic phenotypic abnormalities, of which subcutaneous ossification may be a presenting feature. The differential diagnosis of cutaneous calcification and ossification is outlined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453149     DOI: 10.1159/000247347

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  3 in total

1.  Osteoma cutis as the presenting feature of albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism.

Authors:  Ki-Heon Jeong; Bark-Lynn Lew; Woo-Young Sim
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

Review 2.  GNAS mutations and heterotopic ossification.

Authors:  Murat Bastepe
Journal:  Bone       Date:  2017-09-06       Impact factor: 4.398

3.  Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.

Authors:  Jean B Regard; Deepti Malhotra; Jelena Gvozdenovic-Jeremic; Michelle Josey; Min Chen; Lee S Weinstein; Jianming Lu; Eileen M Shore; Frederick S Kaplan; Yingzi Yang
Journal:  Nat Med       Date:  2013-09-29       Impact factor: 53.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.